tirzépatide perte de poids FL006 et maintien la de au cours du temps Saxenda (liraglutide), Wegovy (sémaglutide), Mounjaro

Otherwise, we risk placing our patients in the worst of all worlds: exposing them to potentially durable harms without sustained benefits.

New drugs such as tirzepatide and emerging candidates like retatrutide promise significant weight loss, but patients understandably wonder how they differ

Most people following the medication protocol lose 15-24% of their body weight over 48 weeks.

If symptoms persist after treatment, recur frequently, or are severe, contact your GP for further evaluation and to review your diabetes medication regimen

Contraindications Tirzepatide is contraindicated in patients with known hypersensitivity to tirzepatide or any other components of this product

SURMOUNT1 Followup (3year study) At 176 weeks, participants on tirzepatide maintained significant weight loss: ~12.3% (5 mg), ~18.7% (10 mg), ~19.7% (15 mg) vs